Driven in part by hospital system consolidation and outcomes-based reimbursement, integrated delivery networks (IDNs) have increasing influence on therapeutic utilization in the United States.

Triangle Insights Group has developed a framework to guide pharmaceutical manufacturers in identifying key factors and stakeholders that are critical to crafting an integrated delivery network strategy that drives commercial success in this evolving landscape.